Subtractive Proteome Mining Approach Towards Unique Putative Drug Targets Identification for Salmonella Typhimurium.
Salmonella typhimurium is rod-shaped bacteria with a Gram-negative genus, belonging to the Enterobacteriaceae family of microbes, invades the intestinal lumen of Human. Salmonella typhimurium is a root source, accounting for gastroenteritis in humans as well as in other mammals. Gastroenteritisis associated with Salmonella Typhimurium by interacting with the contaminated food and water, spread to nearby people in the area. Small intestines are attacked by Salmonella and then enter into the bloodstream momentarily, and are responsible for millions of mortalities and morbidities around the globe. Salmonella typhimurium toxins cause gastrointestiritis due to inflammation in the stomach and intestine in infants and young children. It accounts for millions of deaths with a higher incidence rate in developing countries. In the current research, subtractive proteome mining has been done to recognize putative drug targets. The proteome was analyzed through blast in order to exclude homologous proteins. Bacterial essential proteins were predicted and the participation of the essential genes in the metabolic pathways has been analyzed. 36 essential genes and 15 unique pathways have been identified as potential drug targets among the total of 1934 proteins. The location of proteins is determined as an outer membrane. 3 proteins out of 36 essential proteins are recognized as putative drug targets. In the future, virtual screening for the evaluation of novel clinical compounds for the identified proteins is effective and valuable for Salmonella Typhimurium infection in Homo sapiens.